CAS 112111-47-4
:(+)-Modafinil
- (+)-Modafinil
- 2-[(S)-(Diphenylmethyl)sulfinyl]acetamide
- Acetamide, 2-[(S)-(diphenylmethyl)sulfinyl]-
- Crl 40983
- Nh 02D
- (S)-(+)-Modafinil
(S)-Modafinil
CAS:Controlled ProductApplications Used for treatment of excessive sleepiness, α1-adrenoceptor agonist.
References Saletu, B., et al.: Int. J. Clin. Pharmacol. Res., 9, 183 (1989), Chemelli, R.M., et al.: Cell, 98, 437 (1999), Purnell, M., et al.: J. Sleep Res., 11, 219 (2002), Dinges, D., et al.: Curr. Med. Res. Opin., 22, 159 (2006)Formula:C15H15NO2SColor and Shape:NeatMolecular weight:273.35Modafinil S-enantiomer CIV ((S)-2-(Benzhydrylsulfinyl)acetamide)
CAS:Controlled ProductOther aromatic organo-sulfur compounds (excluding pesticides)Formula:C15H15NO2SColor and Shape:White Off-White SolidMolecular weight:273.08235(S)-Modafinil
CAS:Controlled ProductModafinil is a racemic mixture of the enantiomers, d-modafinil and l-modafinil. It is a wakefulness promoting agent that has been approved for the treatment of narcolepsy in the US, EU, Canada, and Australia. Modafinil binds to the dopamine transporter and blocks its activity, which increases extracellular dopamine levels. It also inhibits the reuptake of serotonin and norepinephrine from their presynaptic terminals, resulting in increased extracellular levels of these neurotransmitters. Modafinil may be useful for treating other disorders such as cocaine dependence and Parkinson's disease.
Formula:C15H15NO2SPurity:Min. 98 Area-%Color and Shape:White To Off-White SolidMolecular weight:273.35 g/molRef: 3D-FM26032
Discontinued product





